Leap Therapeutics
LPTX
LPTX
25 hedge funds and large institutions have $17.8M invested in Leap Therapeutics in 2018 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
25% less capital invested
Capital invested by funds: $23.8M → $17.8M (-$6.06M)
Holders
25
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$403K | |
| 2 | +$376K | |
| 3 | +$206K | |
| 4 |
JPMorgan Chase & Co
New York
|
+$111K |
| 5 |
DS
DRW Securities
Chicago,
Illinois
|
+$77.9K |
Top Sellers
| 1 | -$2M | |
| 2 | -$1.3M | |
| 3 | -$683K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$233K |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$85.7K |